The discovery and development of small molecule immune potentiators (SMIPs) as next-generation vaccine adjuvants, the creation of AS37

Elvira Ianni, Daniela Stranges, Derek T O’Hagan

Open source

DOI
10.1016/j.coviro.2026.101568
Published
2026-12
Container
Current Opinion in Virology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.coviro.2026.101568,
  title = {The discovery and development of small molecule immune potentiators (SMIPs) as next-generation vaccine adjuvants, the creation of AS37},
  author = {Elvira Ianni and Daniela Stranges and Derek T O’Hagan},
  year = {2026},
  journal = {Current Opinion in Virology},
  doi = {10.1016/j.coviro.2026.101568},
  url = {https://doi.org/10.1016/j.coviro.2026.101568}
}

RIS

TY  - JOUR
TI  - The discovery and development of small molecule immune potentiators (SMIPs) as next-generation vaccine adjuvants, the creation of AS37
AU  - Elvira Ianni
AU  - Daniela Stranges
AU  - Derek T O’Hagan
PY  - 2026
JO  - Current Opinion in Virology
DO  - 10.1016/j.coviro.2026.101568
UR  - https://doi.org/10.1016/j.coviro.2026.101568
ER  - 

APA

Ianni, E., Stranges, D., & O’Hagan, D. T. (2026). The discovery and development of small molecule immune potentiators (SMIPs) as next-generation vaccine adjuvants, the creation of AS37. Current Opinion in Virology. https://doi.org/10.1016/j.coviro.2026.101568

Source records